At least they updated shareholders as to something they thought could take place in Q3. Not everyone can say the same. Trial results posted to the FDA clinical website yesterday. New trial is registered and sites are recruiting. Just waiting for first dose. Patience and hope or sell and monitor would be my suggestion.
Market Data 
Markets 
AI
